[VYNE] YoY Quarter Result on 31-Mar-2020 [#Q1]

Stock
[VYNE] VYNE Therapeutics Inc.
Announcement Date
11-May-2020
Financial Year
2020
Quarter
31-Mar-2020 [#Q1]
Profit Trend
QoQ- -87.15%
YoY- -113.18%
Quarter Report
VYNE's Result
VYNE's Financial Summary
View:
Show?
Quarter Result
31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 CAGR
Revenue 99 178 4,119 1,750 0 497 449 -22.26%
PBT -5,612 -8,694 -20,550 -40,233 -18,873 -12,657 -5,474 0.41%
Tax 10 -13,364 1,005 728 0 0 0 -
NP -5,622 4,670 -20,550 -40,233 -18,873 -12,657 -5,474 0.44%
Tax Rate - - - - - - - -
Total Cost 5,721 -4,492 24,669 41,983 18,873 13,154 5,923 -0.57%
Ratio Analysis
31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 CAGR
NP Margin -5,678.79 2,623.60 -498.91 -2,299.03 0.00 -2,546.68 -1,219.15 29.21%
Per Share
31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 CAGR
EPS -1.72 1.52 -7.57 -68.15 -58.35 -51.83 -34.16 -39.21%
EPS Diluted -1.72 1.52 -7.57 -68.15 -58.35 -51.83 -34.16 -39.21%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.